Bronchoscopic Interventional Therapy Combined With Pembrolizumab in the Treatment of Pulmonary Large Cell Neuroendocrine Carcinoma: A Case Report

Yingyi Fan; Yingying Wang; Yanrong Ji; Shuang Li; Jian Zhang; Xingliang Hao

doi:10.1111/crj.70009

The Clinical Respiratory Journal (Sep 2024)

Bronchoscopic Interventional Therapy Combined With Pembrolizumab in the Treatment of Pulmonary Large Cell Neuroendocrine Carcinoma: A Case Report

Yingyi Fan,
Yingying Wang,
Yanrong Ji,
Shuang Li,
Jian Zhang,
Xingliang Hao

Affiliations

Yingyi Fan: Department of Respiratory and Critical Care Medicine Shengli Oilfield Central Hospital Dongying China
Yingying Wang: Clinical Pharmacy of Pharmacy Department Shengli Oilfield Central Hospital Dongying China
Yanrong Ji: Department of Respiratory and Critical Care Medicine Shengli Oilfield Central Hospital Dongying China
Shuang Li: Department of Respiratory and Critical Care Medicine Shengli Oilfield Central Hospital Dongying China
Jian Zhang: Department of Respiratory and Critical Care Medicine Shengli Oilfield Central Hospital Dongying China
Xingliang Hao: Department of Respiratory and Critical Care Medicine Shengli Oilfield Central Hospital Dongying China

DOI: https://doi.org/10.1111/crj.70009
Journal volume & issue: Vol. 18, no. 9
pp. n/a – n/a

Abstract

Read online

ABSTRACT This study reports a significant clinical outcome following the use of bronchoscopic interventional therapy combined with pembrolizumab for treating pulmonary large cell neuroendocrine carcinoma (LCNEC), showcasing a novel approach in managing this aggressive cancer.

Published in The Clinical Respiratory Journal

ISSN: 1752-6981 (Print); 1752-699X (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
Website: https://onlinelibrary.wiley.com/journal/1752699x

About the journal

Abstract

Keywords